NYSE$IQV
IQVIA Holdings Inc. · Q4 2023 earnings
Q4 2023 earnings · · Investor relations
Briefing
IQVIA's Q4 2023 performance showed revenue growth and increased GAAP net income, driven by strong clinical demand in R&DS, while issuing full-year 2024 guidance.
IQVIA reported a 3.5% increase in revenue for Q4 2023, reaching $3,868 million. GAAP Net Income increased significantly to $469 million, and GAAP Diluted Earnings per Share rose to $2.54. The company issued full-year 2024 guidance, projecting revenue between $15,400 million and $15,650 million.
- Q4 revenue reached $3,868 million, a 3.5% increase year-over-year.
- GAAP Net Income for Q4 was $469 million, up 106.6% year-over-year.
- R&D Solutions quarterly bookings exceeded $2.8 billion with a book-to-bill ratio of 1.31x.
- Full-year 2024 revenue is projected to be between $15,400 million and $15,650 million.
Headline financials
Revenue & EPS history
IQVIA · Revenue · Quarterly
$3.87B
Revenue by segment
IQVIA · $3.74B total across 3 segments · Q3 2023
- Research & Development Solutions$2.12B+7.2%56.8%
- Technology & Analytics Solutions$1.43B+2.2%38.3%
- Contract Sales & Medical Solutions$183M+0.0%4.9%
Forward guidance
For the full year 2024, the company expects revenue to be between $15,400 million and $15,650 million, Adjusted EBITDA to be between $3,700 million and $3,800 million, and Adjusted Diluted Earnings per Share to be between $10.95 and $11.25.
Tailwinds
- Revenue guidance assumes approximately $300 million of COVID-related revenue step down.
- Revenue guidance includes about 50 basis points of headwind from foreign exchange.
- Revenue guidance includes about 100 basis points of contribution from acquisitions.
- Adjusted EBITDA is expected to be between $3,700 million and $3,800 million.
- Adjusted Diluted Earnings per Share is expected to be between $10.95 and $11.25.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q4 2023
+1.4%
Avg return
Earnings day
+1.6%
Avg return
5 days after
+1.9%
Avg return
30 days after
65%
37 / 57 earnings
Positive
+12.5%
Q2 2018
Best reaction
-10.7%
Q4 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +7.7% | +10.9% | +13.9% | |
| Q4 2025 | -10.7% | -9.9% | -13.8% | |
| Q3 2025 | +0.3% | -0.4% | +6.6% | |
| Q2 2025 | -0.4% | +1.1% | -1.6% | |
| Q1 2025 | -4.0% | -2.2% | -3.2% | |
| Q4 2024 | +2.2% | -2.2% | -6.7% | |
| Q3 2024 | -3.2% | -1.5% | -7.0% | |
| Q2 2024 | +6.3% | +6.7% | +10.0% | |
| Q1 2024 | -4.1% | -1.6% | -5.9% | |
| Q4 2023 | +12.2% | +10.8% | +17.4% | |
| Q3 2023 | +5.3% | +9.7% | +20.0% | |
| Q2 2023 | -2.1% | -3.1% | -0.5% | |
| Q1 2023 | -0.9% | -2.3% | +5.0% | |
| Q4 2022 | +0.8% | -1.4% | -14.4% | |
| Q3 2022 | +1.4% | +6.1% | +11.3% | |
| Q2 2022 | +0.5% | -0.4% | +8.3% | |
| Q1 2022 | +6.1% | +5.0% | +6.7% | |
| Q4 2021 | -3.2% | -4.8% | -6.9% | |
| Q3 2021 | +2.1% | +1.8% | +6.6% | |
| Q2 2021 | -0.8% | +0.2% | +4.5% | |
| Q1 2021 | +6.1% | +7.0% | +9.1% | |
| Q4 2020 | +4.9% | +4.8% | +1.6% | |
| Q3 2020 | +3.2% | +2.1% | +3.4% | |
| Q2 2020 | +2.9% | +3.4% | +0.4% | |
| Q1 2020 | +8.5% | +3.5% | +10.9% | |
| Q4 2019 | +2.5% | +1.6% | -26.6% | |
| Q3 2019 | -3.8% | -2.4% | -2.7% | |
| Q2 2019 | +2.1% | +1.6% | -2.3% | |
| Q1 2019 | -2.0% | -0.1% | -2.2% | |
| Q4 2018 | +7.6% | +7.3% | +7.4% | |
| Q3 2018 | -3.5% | -5.3% | -8.4% | |
| Q2 2018 | +12.5% | +8.2% | +11.7% | |
| Q1 2018 | -0.7% | +0.2% | +2.6% | |
| Q4 2017 | +1.5% | +1.7% | +5.6% | |
| Q3 2017 | +6.1% | +6.5% | +2.7% | |
| Q2 2017 | -1.3% | -1.0% | +4.4% | |
| Q1 2017 | -3.7% | -2.0% | +3.0% | |
| Q4 2016 | -2.7% | -4.1% | +0.5% | |
| Q3 2016 | +0.8% | +4.1% | +3.3% | |
| Q2 2016 | +3.3% | +4.2% | +0.3% | |
| Q1 2016 | -5.9% | — | — | |
| Q4 2015 | +3.6% | — | — | |
| Q3 2015 | -6.2% | — | — | |
| Q2 2015 | +2.6% | — | — | |
| Q1 2015 | -4.9% | — | — | |
| Q4 2014 | +4.3% | — | — | |
| Q3 2014 | +0.9% | — | — | |
| Q2 2014 | -3.1% | — | — | |
| Q1 2014 | +0.4% | — | — | |
| Q4 2011 | +7.5% | — | — | |
| Q4 2013 | +7.5% | — | — | |
| Q3 2012 | +0.1% | — | — | |
| Q3 2013 | +0.1% | — | — | |
| Q2 2012 | +0.8% | — | — | |
| Q2 2013 | +0.8% | — | — | |
| Q1 2012 | +5.0% | — | — | |
| Q4 2012 | +5.0% | — | — | |
| Q1 2013 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro